Blog

  • Reality of drinking raw eggs as viral trend explained

    Plenty of folks have recreated the infamous Rocky scene where Sylvester Stallone memorably started the day off by necking five raw eggs.

    Although consuming this yellow concoction has become something of a health trend online, a lot of people…

    Continue Reading

  • Cardiovascular research scientist says never ignore these 3 early warning signs of heart disease: ‘Swelling in feet or…’

    Cardiovascular research scientist says never ignore these 3 early warning signs of heart disease: ‘Swelling in feet or…’

    Published on: Oct 26, 2025 07:47 pm IST

    Heart disease often develops silently. Cardiovascular research scientist Dr James DiNicolantonio shares 3 subtle early warning signs everyone should know.

    Heart disease remains one of the…

    Continue Reading

  • The Toyota Supra Officially Dies Early Next Year

    The Toyota Supra Officially Dies Early Next Year

    Toyota has announced it will end Supra production next March, with 2026 being the car’s last model year. The automaker already introduced the Final Edition, which…

    Continue Reading

  • Gauging Valuation After Recent Modest Gains in Autonomous Vehicle Tech

    Gauging Valuation After Recent Modest Gains in Autonomous Vehicle Tech

    Aurora Innovation (AUR) shares have edged slightly higher recently, following a modest uptick of about 2% in the last day and smaller gains over the past week. Investors seem to be weighing the company’s performance during the month, as Aurora continues its work in autonomous vehicle technology.

    See our latest analysis for Aurora Innovation.

    Zooming out, Aurora Innovation’s 1-year share price return is still down double digits, while its three-year total shareholder return remains notably positive. After a recent stretch of modest gains, momentum is still searching for its footing as investors gauge the company’s long-term roadmap and evolving risk profile.

    If Aurora’s recent moves have you reflecting on shifts across the sector, now is the perfect time to explore innovation on a broader scale through the See the full list for free.

    With shares trading well below analyst price targets and impressive long-term gains in the rearview, investors now face a critical question: Is Aurora a bargain poised for growth, or is the market already factoring in its future potential?

    At a price-to-book ratio of 4.8x, Aurora Innovation trades below its peer average of 5.9x based on this valuation measure. This suggests the stock is relatively more attractively priced compared to similar companies. With the last close at $5.15, this indicates the market is discounting Aurora relative to its book value more than its immediate peer group.

    The price-to-book ratio compares a company’s market value to its net asset value. This metric is particularly relevant for asset-light and high-growth sectors like software and autonomous vehicles. For Aurora, this ratio reflects what investors are willing to pay for the company’s equity compared to the book value recorded on its balance sheet.

    This valuation suggests investors may be skeptical about Aurora’s path to profitability or are discounting near-term challenges, despite the sector’s broader appetite for growth. However, the company’s price-to-book still remains higher than the US Software industry average of 4x. This signals the market may still be assigning a premium for its technology or future prospects relative to the average US software company, though less so compared to its closest peers.

    See what the numbers say about this price — find out in our valuation breakdown.

    Result: Price-to-Book of 4.8x (UNDERVALUED compared to peers)

    However, continued net losses and uncertainty around the company’s path to profitability remain challenges that could weigh on future share performance.

    Find out about the key risks to this Aurora Innovation narrative.

    While the price-to-book ratio offers one angle on Aurora’s value, the SWS DCF model provides a different perspective. According to our DCF analysis, Aurora shares are currently trading about 37.8% below our estimate of their fair value. This suggests a considerable undervaluation if you believe the model’s assumptions.

    Look into how the SWS DCF model arrives at its fair value.

    AUR Discounted Cash Flow as at Oct 2025

    Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Aurora Innovation for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

    If you see the story differently or want to dig into the numbers yourself, you can craft your own take in just a few minutes with Do it your way.

    A great starting point for your Aurora Innovation research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

    Smart investors never settle for just one option. Supercharge your research by tapping into untapped potential, income opportunities, and innovation leaders before the crowd moves in.

    • Uncover companies reshaping artificial intelligence and automation by reviewing these 27 AI penny stocks. These firms are disrupting industries with bold advancements and new business models.

    • Generate steady income streams by assessing these 17 dividend stocks with yields > 3%. These options offer attractive yields and strong fundamentals for long-term growth.

    • Capitalize on unique trends in decentralized finance by evaluating these 80 cryptocurrency and blockchain stocks. These selections are positioned at the frontier of digital finance and next-generation payment solutions.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include AUR.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Integrating GLP-1 Therapy, Advancing CSU Care, and Expanding Access

    Integrating GLP-1 Therapy, Advancing CSU Care, and Expanding Access

    GLP-1 Receptor Agonists and Psoriasis

    According to Serota, dermatologists should recognize obesity as a chronic inflammatory condition that often exacerbates inflammatory skin diseases such as psoriasis. “If your patient is overweight or obese,…

    Continue Reading

  • World’s First Private Space Station, Haven-1 sets world record

    World’s First Private Space Station, Haven-1 sets world record

    Long Beach, California, United State–Haven-1, developed by the American company
    Vast, a single-module station designed to launch in May 2026 on a SpaceX Falcon 9 rocket and will support up to four astronauts for short-duration missions,…

    Continue Reading

  • Perioperative Antibiotic Administration Review: An Analysis of Outpatient Surgeries at OhioHealth Doctors Hospital

    Perioperative Antibiotic Administration Review: An Analysis of Outpatient Surgeries at OhioHealth Doctors Hospital

    Continue Reading

  • Pneumococcal Conjugate Vaccines Reduces Incidence of Pneumonia for Children 2 Years and Under

    Pneumococcal Conjugate Vaccines Reduces Incidence of Pneumonia for Children 2 Years and Under

    Pneumococcal conjugate vaccines (PCV) reduced the incidence of pneumonia and improved levels of IgG antibodies in pediatric patients, according to results of a study published in Frontiers in Pediatrics. However, there is a lack of data on…

    Continue Reading

  • Google’s Gemini will now generate presentations for you

    Google’s Gemini will now generate presentations for you

    Google is rolling out out a new feature for Gemini’s Canvas, the free interactive workspace inside the AI chatbot’s app, meant for students and employees who need to create presentations. Gemini is now capable of generating slides with just a…

    Continue Reading

  • This New York City Penthouse Feels Like a Boutique Hotel—and Fits 20 for Thanksgiving

    This New York City Penthouse Feels Like a Boutique Hotel—and Fits 20 for Thanksgiving

    When a far-flung family decided to create a pied-à-terre in downtown Manhattan where they could all gather, they envisioned something warm and welcoming but with a definite New York state of mind. It also had to be big enough to accommodate…

    Continue Reading